TGF-β RII Antibody, anti-human, REAfinity™
Synonyms: TGF beta Receptor II, TGFR-2, TbetaR-II
RECOMBINANT EXTENDED VALIDATION
Bioz Star92/100 Bioz rating
8 Citations4 Images
Clone:
REA903 | MM0056-4F14
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for TGF-β RII Antibody, anti-human, REAfinity™

Flow cytometry applications
APC
APC-Vio 770
Biotin
FITC
PE
PE-Vio 615
PE-Vio 770
Vio Bright B515
Vio Bright R720
Vio Bright V423
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-115-025, 130-115-067
Description:
A mixture of coated and uncoated Latex beads with recombinant human TGF-β RII protein were stained with Anti-TGF-β RII antibodies or with the corresponding REA Control (S) antibodies as well as with Anti-IgG1 antibodies. Flow cytometry was performed using the MACSQuant® Analyzer.

Application imageView details view details

Application imageView details view details
MICS (MACSima Imaging Cyclic Staining) applications
APC
FITC
PE
Fixation:
FFPE
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-115-025, 130-115-067
Testing grade:
Fixation:
frozen – Acetone
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-115-025, 130-115-067
Testing grade:
Extended validation for TGF-β RII Antibody, anti-human, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA903
MM0056-4F14
high
W17055E
high
25508
partial
Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for TGF-β RII. Latex beads coated with recombinant human TGF-β RII protein were stained with TGF-β RII antibodies and with a suitable counterstaining. As a control, TGF-β RII antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for TGF-β RII Antibody, anti-human, REAfinity™
Overview

Clone REA903 recognizes the human transforming growth receptor beta 2 (TGF-β RII) antigen, a single-pass transmembrane protein belonging to the superfamily of serine/threonine kinase receptors. Members of this family bind different TGF-β cytokines (TGF-β1, TGF-β2, TGF-β3) and other growth factors and cytokine signaling proteins. The association between TGF-β RII and TGF-β2 phosphorylates proteins, that regulate the transcription of a subset of genes related to cell proliferation in the nucleus.

Additional information: Clone REA903 displays negligible binding to Fc receptors.

Alternative names

TGF beta Receptor II, TGFR-2, TbetaR-II

Detailed product information

Technical specifications

Clone
REA903
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (S), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
TGF-β RII
Molecular mass of antigen [kDa]
62
Distribution of antigen
macrophages, other
Entrez Gene ID
RRID
AB_2922243, AB_2922200, AB_2726854, AB_2726855, AB_2726853, AB_2726887, AB_2726856, AB_2726888, AB_2922329, AB_2922343, AB_2726890, AB_2922330, AB_2922344, AB_2928924, AB_2928923, AB_2726889

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for TGF-β RII Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?

Copyright © 2026 Miltenyi Biotec and/or its affiliates. All rights reserved.